Scientists are developing on-target HIV vaccines to avoid unhelpful immune responses
Is germline targeting the future of HIV vaccine development?
Antibodies that ‘wait and pounce’ generated by promising HIV vaccine candidate
Mosaico trial closure shifts vaccine focus to neutralising antibodies
Closure of HIV vaccine study shows how far we have to go
Revolutionary HIV vaccine that ‘trains’ the immune system passes its first hurdle
A cure must be a cure for all: why more HIV cure research in Africa is needed
Minimal antibody response in Imbokodo compels change of course for HIV vaccine research
Top 5 HIV cure and vaccine stories from CROI 2022
